查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853760

外科手套市场按材料、最终用户、类型、粉末、分销管道和应用划分－2025-2032年全球预测

Surgical Gloves Market by Material, End User, Type, Powder, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，外科手套市场规模将成长至 39.6 亿美元，复合年增长率为 6.16%。

关键市场统计数据
基准年2024年 24.6亿美元
预计年份：2025年 26.1亿美元
预测年份 2032 39.6亿美元
复合年增长率 (%) 6.16%

外科手套产业处于临床安全、供应链复杂性和不断发展的材料科学的交汇点，因此对医疗机构和采购团队都至关重要。近年来，对更高性能防护屏障的需求不断增长，加之监管审查的加强和生产地域的转移，相关人员更加关注品质、可追溯性和成本效益。本分析综合了目前影响采购决策和营运风险的驱动因素，重点在于材料选择、临床应用和分销方式如何共同影响临床结果和医疗机构预算。

在医疗保健领域，采购负责人必须权衡感染预防的需求与产品舒适度和临床医生偏好等实际问题。同时，製造商面临创新聚合物配方、减少环境足迹以及确保批次间品质一致性的压力。因此，不断演进的筹资策略、检验方案和库存管理实务对于提升组织韧性变得日益重要。本导言将重点介绍决策者可用于优化安全性、供应连续性和整体拥有成本的策略槓桿，以期在不影响临床疗效的前提下，为后续章节奠定基础。

材料突破、监管趋严、采购管道演变以及临床实践改变如何改变供应商和买家的策略

外科手套市场正经历显着的变革，这主要受多种因素驱动，这些因素正在改变供应商格局、产品系列和临床实践。首先，材料创新正在加速发展。新型聚合物和改良的丁腈配方拓展了手套的质地和过敏原抑制选择，迫使临床医生和采购团队重新评估他们的偏好。其次，对无菌保证、细胞毒性特征和生产可追溯性的日益重视，也提高了监管和品质方面的要求。

此外，随着直销、经销商合作和数位商务竞相提供成本透明度、速度和客製化服务，分销和采购模式也在不断演变。这种转变促使人们越来越重视生产和包装中的永续性实践，买家的选择标准也不再局限于单价。最后，临床应用模式的改变，例如门诊手术和外科专科的兴起，正在重塑需求格局。因此，能够将产品创新、监管稳健性和灵活的市场推广模式与新型医疗服务模式结合的企业，将成为策略赢家。

评估美国关税政策调整对2025年之前进口的累积供应链、采购和采购影响

影响美国贸易和关税政策至2025年的政策变化，为外科手套价值链带来了新的复杂性，其累积影响波及从原材料采购到医院采购的各个环节。儘管官方税率和具体分类会随时间变化，但其整体影响却始终如一。不断上涨的进口成本引发了关于製造业回流、供应商选择标准改变的讨论，并促使买家重新评估库存策略，以降低跨境成本波动带来的风险。因此，製造商和经销商正在评估各种方案，例如调整合约价格、对冲采购管道风险以及实现供应商多元化，以维持利润率和产品供应。

实际上，由于供应商寻求长期合约以应对不断上涨的成本压力或稳定销售量，医疗机构和采购集团很可能面临艰难的谈判週期。同时，我们也看到上游生产商为了保障供应安全和降低物流复杂性，正在加速投资国内或近海地区的产能。虽然监管合规和认证的时间可能会延长新参与企业市场的国内企业的上市路径，但降低关税风险的策略吸引力使得这种转型成为可行的中期应对措施。最终，累积的关税环境凸显了积极进行情境规划、供应商风险评估和合作式合约的重要性，以确保财务纪律和临床服务的连续性。

综合細項分析揭示了材料选择、临床环境、产品类型、粉末偏好和分销管道如何影响采购决策。

透过综合考虑产品属性、终端用户环境和分销模式，而非单独考虑，可以获得有意义的市场区隔洞察。乳胶、丁腈橡胶、聚异戊二烯和乙烯基材料之间的差异造就了各自独特的价值提案。乳胶为部分临床医生提供传统的弹性和贴合性等性能；丁腈橡胶具有广泛的耐化学性和较低的致敏性；聚异戊二烯在不含天然橡胶蛋白的情况下实现了类似乳胶的触感；而乙烯基材料对于低风险、短时手术而言仍然是一种经济实惠的选择。这些材料特性与临床应用需求相互作用，因为心血管外科、一般外科、整形外科、整形外科和重组外科等外科专科对触感、抗穿刺性和无菌保证的要求各不相同。

终端使用者群体进一步细化了筹资策略，因为门诊手术中心、诊所、诊断中心和医院各自的业务量、采购管治和临床工作流程各不相同。门诊手术中心，无论是医院附属的还是独立的，通常优先选择与其业务量相符的特定套件。而诊所，包括门诊病人诊所和综合诊所，则专注于更广泛的低危险到中等危重度的诊疗任务，可能更倾向于非无菌或无粉的医疗用品。诊断中心，例如影像中心和病理实验室，对手套有独特的要求，特别注重污染控制和耐化学腐蚀性；而医院，无论是公立还是私立，都需要扩充性的无菌用品来满足其手术量的需求。

非无菌和无菌产品的细分直接影响供应链安全和库存管理。无菌外科手套需要有效的灭菌和低温运输管理，这导致前置作业时间更长，认证门槛更高。无粉和有粉手套的选择持续影响临床医生的偏好和监管核准。在交叉过敏和伤口污染问题较为突出的领域，无粉手套越来越受欢迎。在线上零售领域，B2B 和 B2C 平台正透过数位化目录、分析驱动的补货和更快捷的比价购物来变革采购模式。将这些细分维度——材料、最终用户、产品类型、粉末、分销管道和应用——结合起来，可以建立一个多维地图，使供应商和买家能够更有针对性地进行产品开发、优化合约条款，并使库存策略与临床需求模式保持一致。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和采购现状，对采购、合规性和供应可靠性产生影响。

区域动态对美洲、欧洲、中东和非洲以及亚太市场的供应韧性、监管预期和采购行为有显着影响。在美洲，筹资策略往往优先考虑与供应商建立一体化关係，并专注于物流可靠性和遵守当地法规结构，同时买家也会评估近岸外包，以降低跨洋运输中断的风险。相较之下，欧洲、中东和非洲的监管和报销环境较为复杂，认证的协调统一以及国家层级的公共采购规则对供应商准入和合约模式有着重大影响。

亚太地区仍是聚合物防护设备的重要生产中心，原料供应与成品製造之间存在着复杂的相互依存关係。因此，区域出口政策、劳动力趋势和环境合规性的变化对全球供应链尤其重要。各利益相关者在不同相关人员采取了不同的策略：美洲地区采用紧急采购和多供应商策略；欧洲、中东和非洲地区专注于严格的验证和临床证据；亚太地区则注重战略供应商关係和产能审核。这些区域趋势共同凸显了製定符合当地监管、物流和临床实际情况的商业策略的重要性，同时也要确保全球供应的连续性。

竞争性和策略性的企业行为，例如对无菌生产能力、可追溯性和服务差异化的投资，决定了供应商的长期选择。

製造商、合约供应商和分销仲介业者之间的竞争动态正因整合、垂直一体化和技术差异化而重塑。大型製造商正投资于品管系统、无菌生产线和可追溯性技术，以满足日益增长的临床和监管要求；而契约製造製造商和自有品牌合作伙伴则在灵活性和成本优化方面展开竞争。经销商和直销机构正透过提供诸如灭菌验证支援、临床人员产品培训计划以及数据主导的库存提案工具等整合服务来增强其价值主张，从而降低缺货和产品过时的风险。

专注于先进聚合物配方和永续性认证的新兴参与企业和专业公司正在创造利基市场机会，尤其是在临床团队寻求传统弹性体替代品的情况下。併购和策略联盟日益普遍，使企业能够确保上游原材料供应和下游分销管道，并更好地控制前置作业时间和产品品质。总体而言，那些展现出强大的合规性、营运韧性和服务导向型商业模式的市场参与企业，最有利于建立长期的机构合作关係，并更好地响应支付方和医疗服务提供方不断变化的需求。

可操作的策略重点，包括多元化采购、以临床为中心的创新以及以服务为导向的商业模式，以增强韧性和客户价值。

产业领导者应采取一系列协调一致的行动，以增强供应链韧性、提升产品质量，并使商业性提案与不断变化的临床需求保持一致。首先，应投资多元化的筹资策略，结合本地生产能力、高效率的二级供应商和库存缓衝，以降低贸易政策变化和物流中断带来的风险。同时，应加快采用能够解决过敏原问题、提供适用于急性外科手术的触觉回馈，并确保灭菌和品质系统符合日益严格的监管要求的材料和产品特性。

在商业性，企业应拓展附加价值服务，例如临床医生培训、无菌验证支援和基于分析的库存管理，以深化客户关係并巩固其高端市场定位。采购团队与临床负责人之间的协作至关重要，有助于实施标准化产品配方、简化评估通讯协定并实现可预测的需求模式。最后，鑑于环境评估在长期供应商选择和续约谈判中日益重要，企业应将永续性和生命週期考量纳入产品开发和包装策略，以符合ESG（环境、社会和治理）优先事项。

研究途径方法，结合一手访谈、营运评估、监管研究和情境分析，以支持可操作的策略洞察。

本研究采用混合方法，整合了主要相关人员访谈、营运审核、监管文件审查和供应链图谱分析，以全面展现现代产业的动态变化。主要访谈对象包括采购负责人、临床终端使用者、生产营运经理和分销合作伙伴，从​​而获得了关于偏好驱动因素、风险接受度和合约行为的定性见解。这些访谈，连同营运审核和生产评估，提供了关于生产能力、灭菌流程和品管系统稳健性的客观测量数据。

我们审查了监管和标准文件，以确保产品属性符合通用认证要求；并透过贸易和物流分析，发现了采购流程中潜在的中断点。必要时，我们运用情境分析，对采购方案进行压力测试，以应对关税波动和产能限制，从而提出切实可行的提案。在整个研究过程中，我们透过多资讯来源资料三角验证以及与产业相关人员的交叉检验，确保资料完整性，从而保证研究结果能够反映实际营运情况，并为商业和临床相关人员提供切实可行的建议。

策略要务综合分析，重点在于阐述整合采购、品质保证和临床协作如何增强韧性和竞争优势。

总之，材料创新、监管环境的改善、筹资策略模式的转变以及政策主导的供应链压力正在重塑外科手套市场格局。这些因素共同作用，迫使製造商、经销商和医疗保健采购商采用更精细的采购、产品差异化和服务策略。积极投资于多元化供应链、无菌生产能力以及以临床医生为中心的产品研发的负责人，将更有能力应对关税相关的成本压力和不断变化的临床需求。

随着医疗机构将安全性和营运效率置于优先地位，能够展现有效品质系统、可追溯性和符合实际情况的商业性解决方案的供应商将更有可能赢得长期伙伴关係。未来发展需要采购、临床管治和供应商管理之间的整合规划，将洞察转化为稳健的合约和临床服务的连续性。积极应对新的需求模式和监管预期的相关人员将确保临床信任和商业性优势。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 乳胶过敏安全性危险性促使无粉丁腈橡胶製品的使用量增加。
  • 投资购买抗菌涂层外科手套，以最大限度降低感染风险并提高病患安全性。
  • 开发可生物降解的外科手套材料，以帮助医院永续性并减少废弃物。
  • 手术手套融合了先进的触觉灵敏度增强技术，以提高外科医生的灵敏度。
  • 透过在手套製造中实施工业4.0自动化和数位化监控，提高了效率
  • 在整形外科和创伤手术中，对长袖口外科手套的需求日益增长，以提供更长的保护。
  • 生产成本降低和原料乳胶供应增加，推动外科手套生产能力转移到亚太地区。
  • 全球各地的市场都加强了对基于 ASTM 和 EN455 框架的外科手套监管标准的执行。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科手套市场：依材料划分

  • 乳胶
  • 腈纶
  • 聚异戊二烯
  • 乙烯基塑料

第九章 依最终用户分類的外科手套市场

  • 门诊手术中心
    • 医院相关
    • 独立
  • 诊所
    • 门诊部
    • 一般医学
  • 诊断中心
    • 影像中心
    • 病理实验室
  • 医院
    • 私立医院
    • 公立医院

第十章 外科手套市场（按类型划分）

  • 非无菌
  • 已灭菌

第十一章 粉末外科手套市场

  • 无粉
  • 粉末

第十二章 外科手套市场依通路划分

  • 直销
  • 经销商
  • 线上零售
    • B2B平台
    • B2C平台

第十三章 外科手套市场：依应用领域划分

  • 心血管外科
  • 一般外科
  • 整形外科
  • 整形外科/重组外科

第十四章 外科手套市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 外科手套市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国外科手套市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Top Glove Corporation Berhad
    • Hartalega Holdings Berhad
    • Kossan Rubber Industries Berhad
    • Ansell Limited
    • Semperit AG Holding
    • Supermax Corporation Berhad
    • Sri Trang Gloves（Thailand）Public Company Limited
    • Riverstone Holdings Limited
    • Kimberly-Clark Corporation
    • Molnlycke Health Care AB
Product Code: MRR-02026C4C915C

The Surgical Gloves Market is projected to grow by USD 3.96 billion at a CAGR of 6.16% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.46 billion
Estimated Year [2025] USD 2.61 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 6.16%

The surgical gloves sector sits at the intersection of clinical safety, supply chain complexity, and evolving material science, making it a critical focal point for healthcare providers and procurement teams alike. In recent years, rising demand for higher-performance barrier protection, coupled with shifts in regulatory scrutiny and manufacturing geographies, has intensified stakeholder attention on quality, traceability, and cost efficiency. This analysis synthesizes current drivers shaping procurement decisions and operational risk, placing emphasis on how material selection, clinical application, and distribution choices collectively influence clinical outcomes and institutional budgets.

Across healthcare settings, procurement leaders must balance infection prevention imperatives with the practicalities of product comfort and clinician preference. At the same time, manufacturers face pressure to innovate on polymer formulations, reduce environmental footprint, and demonstrate consistent lot-to-lot quality. Consequently, transitions in sourcing strategies, validation protocols, and inventory management practices are increasingly central to institutional resilience. This introduction frames the subsequent sections by highlighting the strategic levers available to decision-makers seeking to optimize safety, supply continuity, and total cost of ownership without compromising clinical performance.

How material breakthroughs, regulatory tightening, evolving procurement channels, and changing clinical practice are collectively altering supplier and buyer strategies

The landscape for surgical gloves is undergoing transformative shifts driven by several converging forces that alter supplier dynamics, product portfolios, and clinical practice. First, material innovation has accelerated; alternative polymers and improved nitrile formulations have expanded options for tactile sensitivity and allergen mitigation, prompting clinicians and procurement teams to reassess prior preferences. Secondly, regulatory and quality expectations are tightening, with increased focus on sterility assurance, cytotoxicity profiles, and manufacturing traceability, which in turn elevates the value of suppliers who can demonstrate robust compliance systems.

Moreover, the distribution and procurement models are evolving as direct sales, distributor partnerships, and digital commerce compete to deliver cost transparency, speed, and customization. This shift is accompanied by an intensified emphasis on sustainability practices across production and packaging, influencing buyer selection criteria beyond unit price. Finally, clinical application patterns-such as growth in ambulatory procedures and specialization of surgical disciplines-are reshaping demand profiles. As a result, strategic winners will be those that align product innovation, regulatory robustness, and flexible go-to-market models to emerging healthcare delivery modalities.

Assessing the cumulative supply chain, sourcing, and procurement consequences of United States tariff policy adjustments affecting imports through 2025

Policy shifts affecting trade and tariffs in the United States through 2025 have imposed a new layer of complexity on the surgical gloves value chain, with cumulative effects reverberating from raw material sourcing to hospital procurement. Although official rates and specific classifications vary over time, the broader implications are consistent: increases in import costs incentivize reshoring conversations, alter supplier selection calculus, and prompt buyers to reassess inventory strategies to mitigate exposure to cross-border cost volatility. In turn, manufacturers and distributors are evaluating options such as contractual price adjustments, hedging procurement pipelines, and diversifying supplier footprints to preserve margin and availability.

In practical terms, healthcare institutions and buying groups are likely to encounter tighter negotiation cycles as suppliers pass through incremental cost pressures or seek longer-term agreements to stabilize volumes. Concurrently, there is an observable acceleration in investment toward domestic or nearshoring capacity among upstream producers, driven by the desire for supply assurance and reduced logistical complexity. Regulatory compliance and certification timelines can lengthen the path to market for new domestic entrants, yet the strategic appeal of reduced tariff exposure makes that transition a viable medium-term response. Ultimately, the cumulative tariff environment emphasizes the need for proactive scenario planning, supplier risk assessment, and collaborative contracting to ensure both fiscal discipline and clinical continuity.

Integrated segmentation analysis revealing how material choices, clinical settings, product type, powder preference, and distribution channels shape procurement decisions

Meaningful segmentation insights emerge when product attributes, end-user environments, and distribution models are considered together rather than in isolation. Material distinctions among latex, nitrile, polyisoprene, and vinyl drive different value propositions: latex still offers legacy performance characteristics in elasticity and fit for some clinicians, nitrile provides broad chemical resistance and reduced allergenicity, polyisoprene approaches latex-like feel without natural rubber proteins, and vinyl remains a cost-effective option for low-risk, short-duration tasks. These material attributes interact with clinical application needs, as surgical specialties such as cardiovascular surgery, general surgery, orthopedic surgery, and plastic and reconstructive surgery demand varying levels of tactile sensitivity, puncture resistance, and sterility assurance.

End-user segmentation further refines procurement strategies because ambulatory surgical centers, clinics, diagnostic centers, and hospitals exhibit distinct volume profiles, purchasing governance, and clinical workflows. Ambulatory surgical centers, whether hospital affiliated or independent, typically prioritize throughput and consistent procedure-specific kits, while clinics-outpatient clinics and polyclinics-focus on a broader set of low-to-medium acuity tasks where non-sterile options and powder-free preferences may predominate. Diagnostic centers such as imaging centers and pathology labs have unique glove requirements that emphasize contamination control and chemical resistance, and hospitals, both private and public, demand scalable sterile supplies aligned with surgical caseloads.

Type segmentation between non-sterile and sterile products directly affects supply chain security and inventory management, as sterile surgical gloves require validated sterilization and cold-chain considerations that extend lead times and qualification barriers. Powder considerations-powder free versus powdered-continue to influence clinician preference and regulatory acceptance, with powder-free options gaining favor where cross-sensitivity and wound contamination concerns are prioritized. Distribution channels of direct sales, distributors, and online retail shape accessibility and purchasing cadence; within online retail, both B2B platforms and B2C platforms are transforming procurement through digital catalogs, analytics-enabled replenishment, and faster comparison-shopping. When these segmentation layers are combined-material, end user, type, powder, distribution channel, and application-they create a multidimensional map that enables suppliers and buyers to target product development, optimize contract terms, and tailor inventory policies to clinical demand patterns.

Regional dynamics and sourcing realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, compliance, and supply reliability

Regional dynamics exert distinct influences on supply resilience, regulatory expectations, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, procurement strategies tend to emphasize consolidated vendor relationships with an eye toward logistical reliability and compliance with local regulatory frameworks, while buyers also evaluate nearshoring to mitigate transoceanic disruption. By contrast, Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement environment where certification harmonization and country-level public procurement rules materially affect supplier access and contracting models.

Asia-Pacific remains a critical production hub for polymer-based protective devices, with complex interdependencies between raw material feedstocks and finished goods manufacturing. As such, shifts in regional export policies, labor dynamics, and environmental compliance are particularly consequential for global supply chains. Across regions, stakeholders are adopting differentiated approaches: contingency sourcing and multi-supplier strategies in the Americas, stringent validation and clinical evidence emphasis in Europe, Middle East & Africa, and strategic supplier relationships and capacity audits in Asia-Pacific. Together, these regional vectors underline the importance of tailored commercial strategies that reflect local regulatory, logistical, and clinical realities while preserving global continuity of supply.

Competitive and strategic company behaviors including investment in sterile capacity, traceability, and service differentiation that determine long-term supplier selection

Competitive dynamics among manufacturers, contract suppliers, and distribution intermediaries are being reshaped by consolidation, vertical integration, and technology-enabled differentiation. Leading producers are investing in quality management systems, sterile manufacturing lines, and traceability technologies to meet heightened clinical and regulatory expectations, while contract manufacturers and private-label partners compete on agility and cost optimization. Distributors and direct-sales organizations are enhancing value propositions by offering integrated services such as sterilization validation support, product training programs for clinical staff, and data-driven inventory optimization tools that reduce stockouts and obsolescence risk.

New entrants and specialty firms focused on advanced polymer formulations and sustainability credentials are creating niche opportunities, particularly where clinical teams seek alternatives to traditional elastomers. Mergers and strategic partnerships are common as firms seek to secure upstream feedstocks or downstream distribution channels, enabling tighter control over lead times and quality. Overall, market participants that demonstrate robust regulatory compliance, operational resilience, and service-oriented commercial models are best positioned to capture long-term institutional relationships and to respond to shifting payer and provider priorities.

Actionable strategic priorities including diversified sourcing, clinical-focused innovation, and service-oriented commercial models to strengthen resilience and customer value

Industry leaders should pursue a set of coordinated actions that strengthen supply resilience, elevate product quality, and align commercial propositions with evolving clinical needs. First, invest in diversified sourcing strategies that combine regional production capacity, validated secondary suppliers, and inventory buffers to reduce exposure to trade-policy shifts and logistical disruptions. At the same time, accelerate adoption of materials and product profiles that address allergen concerns and deliver tactile performance suitable for high-acuity surgical specialties, while ensuring sterilization and quality systems meet tightening regulatory expectations.

Commercially, firms should expand value-added service offerings such as clinician education, sterile validation support, and analytics-enabled inventory management to deepen customer relationships and justify premium positioning. Collaboration between procurement teams and clinical leaders will be essential to implement standardized product formularies, streamline evaluation protocols, and realize predictable demand patterns. Finally, embed sustainability and lifecycle considerations into product development and packaging strategies to align with institutional ESG priorities, recognizing that environmental credentials increasingly factor into long-term supplier selection and contract renewal discussions.

Mixed-method research approach combining primary interviews, operational assessments, regulatory review, and scenario analysis to support actionable strategic insights

This research draws on a mixed-methods approach that integrates primary stakeholder interviews, operational audits, regulatory document review, and supply chain mapping to create a comprehensive view of contemporary dynamics. Primary interviews included procurement leads, clinical end users, manufacturing operations managers, and distribution partners, yielding qualitative insights into preference drivers, risk tolerance, and contractual behaviors. Complementing these interviews, operational audits and manufacturing assessments provided objective measures of production capabilities, sterilization workflows, and quality management system robustness.

Regulatory and standards documentation was reviewed to align product attributes with prevailing certification expectations, while trade and logistics analyses illuminated potential disruption points across sourcing routes. Where appropriate, scenario analysis was applied to stress-test sourcing options against tariff volatility and capacity constraints, enabling pragmatic recommendations. Throughout the research process, data integrity was maintained through triangulation across multiple sources and cross-validation with industry practitioners to ensure that findings reflect operational realities and actionable implications for commercial and clinical stakeholders.

Synthesis of strategic imperatives highlighting how integrated sourcing, quality assurance, and clinical collaboration drive resilience and competitive advantage

In conclusion, the surgical gloves landscape is being reconstituted by material innovation, regulatory refinement, shifting distribution paradigms, and policy-driven supply chain pressures. These factors collectively compel manufacturers, distributors, and healthcare purchasers to adopt more sophisticated sourcing, product differentiation, and service strategies. Organizations that proactively invest in diversified supply footprints, sterile manufacturing capability, and clinician-focused product development will be better positioned to navigate tariff-related cost pressures and evolving clinical requirements.

As providers prioritize both safety and operational efficiency, the suppliers that can demonstrate validated quality systems, traceability, and contextualized commercial solutions will win durable partnerships. The path forward requires integrated planning across procurement, clinical governance, and supplier management to translate intelligence into resilient contracts and clinical continuity. Stakeholders who act decisively to align capabilities with emerging demand patterns and regulatory expectations will secure both clinical trust and commercial advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of powder free nitrile surgical gloves driven by latex allergy safety concerns
  • 5.2. Investment in antimicrobial coated surgical gloves to minimize infection risk and enhance patient safety
  • 5.3. Development of biodegradable surgical glove materials to support hospital sustainability and waste reduction
  • 5.4. Integration of advanced tactile sensitivity enhancements in surgical gloves to improve surgeon dexterity
  • 5.5. Adoption of Industry 4.0 automation and digital monitoring in glove manufacturing to boost efficiency
  • 5.6. Growing demand for longer cuff surgical gloves in orthopedic and trauma surgeries for enhanced protection coverage
  • 5.7. Shift of surgical glove manufacturing capacity to Asia-Pacific regions driven by lower production costs and raw latex supply
  • 5.8. Heightened regulatory standards enforcement for surgical gloves under ASTM and EN455 frameworks across global markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Gloves Market, by Material

  • 8.1. Latex
  • 8.2. Nitrile
  • 8.3. Polyisoprene
  • 8.4. Vinyl

9. Surgical Gloves Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Hospital Affiliated
    • 9.1.2. Independent
  • 9.2. Clinics
    • 9.2.1. Outpatient Clinics
    • 9.2.2. Polyclinics
  • 9.3. Diagnostic Centers
    • 9.3.1. Imaging Centers
    • 9.3.2. Pathology Labs
  • 9.4. Hospitals
    • 9.4.1. Private Hospitals
    • 9.4.2. Public Hospitals

10. Surgical Gloves Market, by Type

  • 10.1. Non Sterile
  • 10.2. Sterile

11. Surgical Gloves Market, by Powder

  • 11.1. Powder Free
  • 11.2. Powdered

12. Surgical Gloves Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail
    • 12.3.1. B2B Platforms
    • 12.3.2. B2C Platforms

13. Surgical Gloves Market, by Application

  • 13.1. Cardiovascular Surgery
  • 13.2. General Surgery
  • 13.3. Orthopedic Surgery
  • 13.4. Plastic & Reconstructive Surgery

14. Surgical Gloves Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Gloves Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Gloves Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Top Glove Corporation Berhad
    • 17.3.2. Hartalega Holdings Berhad
    • 17.3.3. Kossan Rubber Industries Berhad
    • 17.3.4. Ansell Limited
    • 17.3.5. Semperit AG Holding
    • 17.3.6. Supermax Corporation Berhad
    • 17.3.7. Sri Trang Gloves (Thailand) Public Company Limited
    • 17.3.8. Riverstone Holdings Limited
    • 17.3.9. Kimberly-Clark Corporation
    • 17.3.10. Molnlycke Health Care AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. SURGICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. SURGICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL GLOVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 340. MI